Atlas Trials

B7-H3 CAR-T for Recurrent or Refractory Glioblastoma

Clinical trial NCT04077866 · UNKNOWN

Trial details

NCT number
NCT04077866
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Recurrent GlioblastomaRefractory Glioblastoma
Start date
2023-06-01
Primary completion
2025-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.